Collegium Pharmaceutical, Inc
COLL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267565
No open-market purchases or sales by Collegium Pharmaceutical, Inc insiders were filed in the last 90 days; 279 institutions reported holding it in 13F filings for Q2 2026, worth $1.42B in total; no superinvestor holds it.
Superinvestors holding COLL, Q2 2026
No superinvestor reported holding COLL in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of COLL each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2024
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2024
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+346.3%)
Q1 2024
1 superinvestor holding at quarter end
Q3 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−7.9%)
Q1 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+5.2%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−27.1%)
Q3 2022
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
1 superinvestor holding at quarter end